Robot-Assisted Totally Intracorporeal Resection of Cutaneous Ureterostomy Tumor and Ileal Conduit Surgery: A Rare Case Report

Radical cystectomy (RC) is the standard treatment for muscular invasive bladder cancer (MIBC) and some high-risk non-muscular invasive bladder cancer (NMIBC). Cutaneous ureterostomy is a common form of urinary diversion. However, after radical cystectomy, recurrence of upper urinary tract malignanci...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in oncology Vol. 12; p. 803221
Main Authors Cai, Lingkai, Zhuang, Juntao, Cao, Qiang, Yuan, Baorui, Wu, Qikai, Li, Kai, Han, Jie, Yu, Hao, Lv, JianCheng, Feng, Dexiang, Liu, Peikun, Yu, Ruixi, Li, Pengchao, Yang, Xiao, Lu, Qiang
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 10.02.2022
Subjects
BCa
cutaneous ureterostomy
ileal conduit
Oncology
recurrence
robot
recurrence
robot
BCa
ileal conduit
cutaneous ureterostomy
Online AccessGet full text

Cover

More Information
Summary:Radical cystectomy (RC) is the standard treatment for muscular invasive bladder cancer (MIBC) and some high-risk non-muscular invasive bladder cancer (NMIBC). Cutaneous ureterostomy is a common form of urinary diversion. However, after radical cystectomy, recurrence of upper urinary tract malignancies is possible. There is no relevant report on how to improve this situation's management. This case is a 56-year-old male patient hospitalized due to the development of a new tumor in the ureteral cutaneous stoma following radical cystectomy for more than five years. A biopsy of the tumor revealed high-grade urothelial carcinoma. Computed tomography (CT) revealed that the local soft tissue around the cutaneous stoma was thickened, but no other lesions were visible. After evaluating the case, we chose robot-assisted completely intracorporeal resection of cutaneous ureterostomy tumor and ileal conduit surgery. The total time for the operation and the blood loss were 400 minutes and 150 ml, respectively. Following surgery, the patient got standard chemotherapy in combination with immunotherapy. Additionally, ten months following the surgery, the patient did not experience disease progression or complications. The robot-assisted operation is safe and feasible for upper urinary tract tumor recurrence following radical cystectomy with cutaneous ureterostomy.
Bibliography:ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
Reviewed by: Alessandro Veccia, Azienda Socio Sanitaria Territoriale di Mantova, Italy; Gianluca Muto, Careggi Hospital, Italy; Luca Lambertini, Careggi University Hospital, Italy
Edited by: Riccardo Tellini, Careggi University Hospital, Italy
These authors have contributed equally to this work
This article was submitted to Genitourinary Oncology, a section of the journal Frontiers in Oncology
ISSN:2234-943X
2234-943X
DOI:10.3389/fonc.2022.803221